Novel potent pyrimido[4,5-c]quinoline inhibitors of protein kinase CK2: SAR and preliminary assessment of their analgesic and anti-viral properties (Q42751003)

From Wikidata

Jump to navigation Jump to search

scientific article published on January 26, 2011

Language	Label	Description	Also known as
English	Novel potent pyrimido[4,5-c]quinoline inhibitors of protein kinase CK2: SAR and preliminary assessment of their analgesic and anti-viral properties	scientific article published on January 26, 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

Novel potent pyrimido[4,5-c]quinoline inhibitors of protein kinase CK2: SAR and preliminary assessment of their analgesic and anti-viral properties (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

author name string

Fabrice Pierre

1

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

Mustapha Haddach

3

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

Pauline Bourbon

4

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

Eric Stefan

6

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

Levan Darjania

7

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

Ryan Stansfield

8

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

Caroline Ho

9

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

Adam Siddiqui-Jain

10

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

Nicole Streiner

11

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

Kenna Anderes

13

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

Sean E. O'Brien

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21316963

24 November 2024

Michael K. Schwaebe

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21316963

24 November 2024

William G. Rice

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21316963

24 November 2024

David M. Ryckman

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21316963

24 November 2024

language of work or name

0 references

publication date

26 January 2011

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

number of pages

5

1 reference

based on heuristic

inferred from page(s)

full work available at URL

https://api.elsevier.com/content/article/PII:S0960894X11001144?httpAccept=text/xml

1 reference

10.1016/J.BMCL.2011.01.091

https://api.crossref.org/works/10.1016/J.BMCL.2011.01.091

24 November 2024

https://api.elsevier.com/content/article/PII:S0960894X11001144?httpAccept=text/plain

1 reference

10.1016/J.BMCL.2011.01.091

https://api.crossref.org/works/10.1016/J.BMCL.2011.01.091

24 November 2024

Bioorganic & Medicinal Chemistry Letters

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

21

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

1687-1691

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

Protein kinase CK2 as a druggable target

2

1 reference

10.1016/J.BMCL.2011.01.091

https://api.crossref.org/works/10.1016/J.BMCL.2011.01.091

24 November 2024

Protein kinase CK2 in human diseases.

3

1 reference

10.1016/J.BMCL.2011.01.091

https://api.crossref.org/works/10.1016/J.BMCL.2011.01.091

24 November 2024

Antitumor activity of pyridocarbazole and benzopyridoindole derivatives that inhibit protein kinase CK2

4

1 reference

10.1016/J.BMCL.2011.01.091

https://api.crossref.org/works/10.1016/J.BMCL.2011.01.091

24 November 2024

Resorufin: a lead for a new protein kinase CK2 inhibitor

5

1 reference

10.1016/J.BMCL.2011.01.091

https://api.crossref.org/works/10.1016/J.BMCL.2011.01.091

24 November 2024

Synthesis of new analogs of benzotriazole, benzimidazole and phthalimide--potential inhibitors of human protein kinase CK2.

6

1 reference

10.1016/J.BMCL.2011.01.091

https://api.crossref.org/works/10.1016/J.BMCL.2011.01.091

24 November 2024

How druggable is protein kinase CK2?

7

1 reference

10.1016/J.BMCL.2011.01.091

https://api.crossref.org/works/10.1016/J.BMCL.2011.01.091

24 November 2024

Development and exploitation of CK2 inhibitors

8

1 reference

10.1016/J.BMCL.2011.01.091

https://api.crossref.org/works/10.1016/J.BMCL.2011.01.091

24 November 2024

Inhibition of protein kinase CK2 expression and activity blocks tumor cell growth

9

1 reference

10.1016/J.BMCL.2011.01.091

https://api.crossref.org/works/10.1016/J.BMCL.2011.01.091

24 November 2024

New protein kinase CK2 inhibitors: jumping out of the catalytic box.

10

1 reference

10.1016/J.BMCL.2011.01.091

https://api.crossref.org/works/10.1016/J.BMCL.2011.01.091

24 November 2024

Targeting CK2 for cancer therapy

11

1 reference

10.1016/J.BMCL.2011.01.091

https://api.crossref.org/works/10.1016/J.BMCL.2011.01.091

24 November 2024

Too much of a good thing: the role of protein kinase CK2 in tumorigenesis and prospects for therapeutic inhibition of CK2.

13

1 reference

10.1016/J.BMCL.2011.01.091

https://api.crossref.org/works/10.1016/J.BMCL.2011.01.091

24 November 2024

Emergence of protein kinase CK2 as a key target in cancer therapy

14

1 reference

10.1016/J.BMCL.2011.01.091

https://api.crossref.org/works/10.1016/J.BMCL.2011.01.091

24 November 2024

Protein kinase CK2 in mammary gland tumorigenesis

15

1 reference

10.1016/J.BMCL.2011.01.091

https://api.crossref.org/works/10.1016/J.BMCL.2011.01.091

24 November 2024

Nuclear localization of protein kinase CK2 catalytic subunit (CK2alpha) is associated with poor prognostic factors in human prostate cancer

16

1 reference

10.1016/J.BMCL.2011.01.091

https://api.crossref.org/works/10.1016/J.BMCL.2011.01.091

24 November 2024

Addiction to protein kinase CK2: a common denominator of diverse cancer cells?

17

1 reference

10.1016/J.BMCL.2011.01.091

https://api.crossref.org/works/10.1016/J.BMCL.2011.01.091

24 November 2024

Spinal CK2 regulates nociceptive signaling in models of inflammatory pain

18

1 reference

10.1016/J.BMCL.2011.01.091

https://api.crossref.org/works/10.1016/J.BMCL.2011.01.091

24 November 2024

Casein kinase-II regulates NMDA channel function in hippocampal neurons

19

1 reference

10.1016/J.BMCL.2011.01.091

https://api.crossref.org/works/10.1016/J.BMCL.2011.01.091

24 November 2024

Phosphorylation of calmodulin alters its potency as an activator of target enzymes

20

1 reference

10.1016/J.BMCL.2011.01.091

https://api.crossref.org/works/10.1016/J.BMCL.2011.01.091

24 November 2024

Carbon monoxide neurotransmission activated by CK2 phosphorylation of heme oxygenase-2

21

1 reference

10.1016/J.BMCL.2011.01.091

https://api.crossref.org/works/10.1016/J.BMCL.2011.01.091

24 November 2024

Casein kinase ii (protein kinase ck2) regulates serotonin 5-ht(3) receptor channel function in ng108-15 cells

22

1 reference

10.1016/J.BMCL.2011.01.091

https://api.crossref.org/works/10.1016/J.BMCL.2011.01.091

24 November 2024

Casein kinase II (CK-II)-mediated stimulation of HIV-1 reverse transcriptase activity and characterization of selective inhibitors in vitro

23

1 reference

10.1016/J.BMCL.2011.01.091

https://api.crossref.org/works/10.1016/J.BMCL.2011.01.091

24 November 2024

Biochemical characterization of casein kinase II as a protein kinase responsible for stimulation of HIV-1 protease in vitro

24

1 reference

10.1016/J.BMCL.2011.01.091

https://api.crossref.org/works/10.1016/J.BMCL.2011.01.091

24 November 2024

Protein kinase CK2 phosphorylates the Nef protein from a neurovirulent simian immunodeficiency virus

25

1 reference

10.1016/J.BMCL.2011.01.091

https://api.crossref.org/works/10.1016/J.BMCL.2011.01.091

24 November 2024

Casein kinase II is a selective target of HIV-1 transcriptional inhibitors

26

1 reference

10.1016/J.BMCL.2011.01.091

https://api.crossref.org/works/10.1016/J.BMCL.2011.01.091

24 November 2024

CX-4945, an Orally Bioavailable Selective Inhibitor of Protein Kinase CK2, Inhibits Prosurvival and Angiogenic Signaling and Exhibits Antitumor Efficacy

27

1 reference

10.1016/J.BMCL.2011.01.091

https://api.crossref.org/works/10.1016/J.BMCL.2011.01.091

24 November 2024

Discovery and SAR of 5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic Acid (CX-4945), the First Clinical Stage Inhibitor of Protein Kinase CK2 for the Treatment of Cancer

28

1 reference

10.1016/J.BMCL.2011.01.091

https://api.crossref.org/works/10.1016/J.BMCL.2011.01.091

24 November 2024

Synthesis of 2-aryl-oxazolo[4,5-c]quinoline-4(5H)-ones and 2-aryl-thiazolo[4,5-c]quinoline-4(5H)-ones

30

1 reference

10.1016/J.BMCL.2011.01.091

https://api.crossref.org/works/10.1016/J.BMCL.2011.01.091

24 November 2024

Protein kinase CK2 phosphorylates and upregulates Akt/PKB.

31

1 reference

10.1016/J.BMCL.2011.01.091

https://api.crossref.org/works/10.1016/J.BMCL.2011.01.091

24 November 2024

Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5,6-dihydroindolo-(1,2-a)quinazolin-7-yl]acetic acid (IQA)

33

1 reference

10.1016/J.BMCL.2011.01.091

https://api.crossref.org/works/10.1016/J.BMCL.2011.01.091

24 November 2024

Protein kinase CK2 in health and disease: Structural bases of protein kinase CK2 inhibition

34

1 reference

10.1016/J.BMCL.2011.01.091

https://api.crossref.org/works/10.1016/J.BMCL.2011.01.091

24 November 2024

Protein kinase CK2 in health and disease: Protein kinase CK2: from structures to insights.

35

1 reference

10.1016/J.BMCL.2011.01.091

https://api.crossref.org/works/10.1016/J.BMCL.2011.01.091

24 November 2024

Crystal structure of human protein kinase CK2: insights into basic properties of the CK2 holoenzyme

36

1 reference

10.1016/J.BMCL.2011.01.091

https://api.crossref.org/works/10.1016/J.BMCL.2011.01.091

24 November 2024

The formalin test in mice: dissociation between inflammatory and non-inflammatory pain

37

1 reference

10.1016/J.BMCL.2011.01.091

https://api.crossref.org/works/10.1016/J.BMCL.2011.01.091

24 November 2024

The formalin test in the mouse: a parametric analysis of scoring properties

38

1 reference

10.1016/J.BMCL.2011.01.091

https://api.crossref.org/works/10.1016/J.BMCL.2011.01.091

24 November 2024

Identifiers

10.1016/J.BMCL.2011.01.091

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42751003&oldid=2279022636"